Uncas Favret III

Ben, VESTEX® founder and president, brings more than three decades of innovation and expertise to the industry and has extensive experience in sales and marketing management, product launches and start-up business leadership. He began his career at Pfizer and emerged as a top salesperson who played a key role in multiple successful drug launches. He followed that with success at biotech start-up Centocor and on to The Liposome Company, where he was instrumental in the launch of the cancer drug, Abelcet®.

Ben later joined Matrix Oncology, which was acquired by Priority Healthcare and merged into Express Scripts. He also served as co-founder and vice president of OneOncology, Inc., a provider of electronic negotiation technology for the oncology drug industry.

Recognizing a new opportunity to deliver advanced performance textile technologies to the healthcare sector, Ben developed VESTEX® to enhance the safety of health care workers and their patients. Expanding into other industry niches, VESTEX® is now FDA Class 2 510(k) cleared and promises to become an industry and consumer choice for protective, anti-microbial, liquid-repellent textile solutions.

Ben holds a Bachelor’s of Science degree from the University of Alabama, has served on the Boards of Directors for the National Kidney Foundation, YMCA of Central Florida and USA Water Ski